The results revealed that high levels of ANO1 and KRAS were associated with activating key genes involved in lipid metabolism like HMGCS1, indicating that ANO1 regulated basic metabolic processes that occured in pancreatic cancer cells. This evidence concerns the gene ANO1 and familial pancreatic carcinoma.